Letter
Published December 10, 2009
Updated December 10, 2009
Letter Supporting the Creation of a Regulatory Pathway for “Biosimilar” Medicines
By:
SUMMARY
Letter in support of the creation of a regulatory pathway for “biosimilar” medicines.
Third Way encourages the creation of a regulatory pathway for “biosimilar” medicines. Third Way has been an ardent supporter of the creation of a regulatory pathway as a way to offer patients access to lower-cost medications.
To read this Letter, open the attached PDF
Downloads
Latest Publications
Memo
Published October 13, 2026
The Heartland Battle Over Hospital Prices: Why Wisconsin Is Losing
Letter
Published October 7, 2026
Making Health Coverage Work for Everyone
One-Pager
Published September 22, 2026
By the Numbers: A Health Care Bill of Rights for Working America
Memo
Published August 6, 2026
Americans Blame the Government for High Health Costs and Want It to Rein in the Industry
Never Miss an Update
Sign up for updates on the pragmatic, center-left ideas shaping the future of American policy.